Skip to search formSkip to main contentSkip to account menu

cetuximab

Known as: Cetuximab [Chemical/Ingredient], Anti-EGFR Monoclonal Antibody, Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 
A recombinant, chimeric monoclonal antibody directed against the epidermal growth factor (EGFR) with antineoplastic activity. Cetuximab binds to the… 
National Institutes of Health

Related topics

Related topics

17 relations
100 ML cetuximab 2 MG/ML Injection50 ML cetuximab 2 MG/ML Injection [Erbitux]Antibody-Dependent Cellular CytotoxicityCisplatin-Cetuximab Regimen

Broader (1)

Antineoplastic Agents

Narrower (2)

ErbituxIMC C225

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Microbubble Therapy Enhances Anti-tumor Properties of Cisplatin and Cetuximab In Vitro and In Vivo
Objective. To determine if microbubble-mediated ultrasound therapy (MB-UST) can improve cisplatin or cetuximab cytotoxicity of… 
Highly Cited
2008
Highly Cited
2008
Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection.
Highly Cited
2008
Highly Cited
2008
Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
Shortwave (MHz range) radiofrequency (RF) energy is nonionizing, penetrates deeply into biologic tissues with no adverse side… 
Highly Cited
2006
Highly Cited
2006
Cetuximab and Irinotecan Interact Synergistically to Inhibit the Growth of Orthotopic Anaplastic Thyroid Carcinoma Xenografts in Nude Mice
Purpose: Anaplastic thyroid carcinoma (ATC) remains one of the most lethal known human cancers. Targeted molecular therapy with… 
Highly Cited
2005
Highly Cited
2005
Evidence for repatterning of the gastric fundic epithelium associated with Ménétrier's disease and TGFalpha overexpression.
BACKGROUND & AIMS Increase of intramucosal transforming growth factor alpha (TGFalpha) levels in the gastric fundus leads to… 
Highly Cited
2005
Highly Cited
2005
Cetuximab in combination with oxaliplatin/5-fluorouracil (5FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic…
3535 Background: Cetuximab (Erbitux), an IgG1 monoclonal antibody that specifically targets EGFR the receptor, is effective in… 
Review
2004
Review
2004
Monoclonal antibodies in the treatment of colorectal cancer.
Highly Cited
1999
Highly Cited
1999
Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast…
Type I protein kinase A (PKAI) is overexpressed in the majority of human tumors and plays a relevant role in neoplastic… 
Highly Cited
1998
Highly Cited
1998
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
BACKGROUND The expression of epidermal growth factor receptor (EGFR) and type I cyclic adenosine monophosphate (cAMP)-dependent… 
Highly Cited
1993
Highly Cited
1993
Nonlinear wave mixing and induced gratings in erbium-doped fiber amplifiers.
We present a study of nonlinear wave mixing in erbium-doped fiber amplifiers. Wave mixing is demonstrated in dynamic gain… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)